Found: 118
Select item for more details and to access through your institution.
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.
- Published in:
- Clinical & Experimental Medicine, 2020, v. 20, n. 2, p. 313, doi. 10.1007/s10238-020-00616-5
- By:
- Publication type:
- Article
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1550, doi. 10.1002/ajh.27400
- By:
- Publication type:
- Article
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 68, doi. 10.1002/ajh.27136
- By:
- Publication type:
- Article
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1829, doi. 10.1002/ajh.27079
- By:
- Publication type:
- Article
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1520, doi. 10.1002/ajh.27013
- By:
- Publication type:
- Article
Diagnostic and therapeutic challenges in mast cell sarcoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 529, doi. 10.1002/ajh.26804
- By:
- Publication type:
- Article
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E470, doi. 10.1002/ajh.26732
- By:
- Publication type:
- Article
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. E347, doi. 10.1002/ajh.26648
- By:
- Publication type:
- Article
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 846, doi. 10.1002/ajh.26548
- By:
- Publication type:
- Article
Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E35, doi. 10.1002/ajh.26423
- By:
- Publication type:
- Article
Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1580, doi. 10.1002/ajh.26336
- By:
- Publication type:
- Article
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1472, doi. 10.1002/ajh.26332
- By:
- Publication type:
- Article
Impaired response to first SARS‐CoV‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E408, doi. 10.1002/ajh.26305
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Lenalidomide: A double‐edged sword for concomitant multiple myeloma and post‐essential thrombocythemia myelofibrosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 749, doi. 10.1002/ajh.26153
- By:
- Publication type:
- Article
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1622, doi. 10.1002/ajh.25806
- By:
- Publication type:
- Article
Genetic lesions disrupting calreticulin 3′‐untranslated region in JAK2 mutation‐negative polycythemia vera.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E263, doi. 10.1002/ajh.25911
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E23, doi. 10.1002/ajh.25668
- By:
- Publication type:
- Article
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 156, doi. 10.1002/ajh.25677
- By:
- Publication type:
- Article
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E1, doi. 10.1002/ajh.25644
- By:
- Publication type:
- Article
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E239, doi. 10.1002/ajh.25555
- By:
- Publication type:
- Article
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 8, p. 845, doi. 10.1002/ajh.25506
- By:
- Publication type:
- Article
The JAK2 46/1 (GGCC) MPN‐predisposing haplotype: A risky haplotype, after all.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 283, doi. 10.1002/ajh.25367
- By:
- Publication type:
- Article
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 615, doi. 10.1002/ajh.25047
- By:
- Publication type:
- Article
<italic>JAK2</italic> exon 12 mutated polycythemia vera: Mayo‐Careggi MPN Alliance study of 33 consecutive cases and comparison with <italic>JAK2</italic>V617F mutated disease.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. E93, doi. 10.1002/ajh.25017
- By:
- Publication type:
- Article
Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 348, doi. 10.1002/ajh.24978
- By:
- Publication type:
- Article
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1193, doi. 10.1002/ajh.24882
- By:
- Publication type:
- Article
A life-threatening ruxolitinib discontinuation syndrome.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 833, doi. 10.1002/ajh.24775
- By:
- Publication type:
- Article
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 187, doi. 10.1002/ajh.24614
- By:
- Publication type:
- Article
The prognostic impact of bone marrow fibrosis in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E454, doi. 10.1002/ajh.24482
- By:
- Publication type:
- Article
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. E356, doi. 10.1002/ajh.24437
- By:
- Publication type:
- Article
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 918, doi. 10.1002/ajh.24442
- By:
- Publication type:
- Article
Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 1, p. 82, doi. 10.1002/ajh.23871
- By:
- Publication type:
- Article
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 8, p. E121, doi. 10.1002/ajh.23743
- By:
- Publication type:
- Article
Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 588, doi. 10.1002/ajh.23694
- By:
- Publication type:
- Article
CALR mutations in myeloproliferative neoplasms: Hidden behind the reticulum.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 453, doi. 10.1002/ajh.23678
- By:
- Publication type:
- Article
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 562, doi. 10.1002/ajh.23169
- By:
- Publication type:
- Article
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 552, doi. 10.1002/ajh.23160
- By:
- Publication type:
- Article
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 245, doi. 10.1002/ajh.22257
- By:
- Publication type:
- Article
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 8, p. 616, doi. 10.1002/ajh.21754
- By:
- Publication type:
- Article
CircRNAs Are Here to Stay: A Perspective on the MLL Recombinome.
- Published in:
- Frontiers in Genetics, 2019, p. N.PAG, doi. 10.3389/fgene.2019.00088
- By:
- Publication type:
- Article
Advances in Understanding and Management of Myeloproliferative Neoplasms.
- Published in:
- CA: A Cancer Journal for Clinicians, 2009, v. 59, n. 3, p. 171, doi. 10.3322/caac.20009
- By:
- Publication type:
- Article
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231205643
- By:
- Publication type:
- Article
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10 9 /L to <100 × 10 9 /L) at baseline: the final analysis of EXPAND.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221118429
- By:
- Publication type:
- Article
Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2859, doi. 10.3390/cancers15102859
- By:
- Publication type:
- Article
Increased Plasma Levels of lncRNAs LINC01268 , GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4744, doi. 10.3390/cancers13194744
- By:
- Publication type:
- Article
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1746, doi. 10.3390/cancers12071746
- By:
- Publication type:
- Article
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 380, doi. 10.1007/s11899-015-0285-y
- By:
- Publication type:
- Article
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01052-4
- By:
- Publication type:
- Article